Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers N Shental, S Levy, V Wuvshet, S Skorniakov, B Shalem, A Ottolenghi, ... Science advances 6 (37), eabc5961, 2020 | 197 | 2020 |
Nanoscale mechanosensing of natural killer cells is revealed by antigen‐functionalized nanowires G Le Saux, N Bar‐Hanin, A Edri, U Hadad, A Porgador, M Schvartzman Advanced Materials 31 (4), 1805954, 2019 | 50 | 2019 |
Inhibition of the NKp44-PCNA immune checkpoint using a mAb to PCNA K Kundu, S Ghosh, R Sarkar, A Edri, M Brusilovsky, O Gershoni-Yahalom, ... Cancer immunology research 7 (7), 1120-1134, 2019 | 28 | 2019 |
Survival in acute myeloid leukemia is associated with NKp44 splice variants A Shemesh, M Brusilovsky, U Hadad, O Teltsh, A Edri, E Rubin, ... Oncotarget 7 (22), 32933, 2016 | 27 | 2016 |
Natural killer cells’ immune response requires a minimal nanoscale distribution of activating antigens Y Keydar, G Le Saux, A Pandey, E Avishay, N Bar-Hanin, T Esti, ... Nanoscale 10 (30), 14651-14659, 2018 | 25 | 2018 |
The Ebola-glycoprotein modulates the function of natural killer cells A Edri, A Shemesh, M Iraqi, O Matalon, M Brusilovsky, U Hadad, ... Frontiers in immunology 9, 1428, 2018 | 23 | 2018 |
Mechanical regulation of the cytotoxic activity of natural killer cells L Mordechay, G Le Saux, A Edri, U Hadad, A Porgador, M Schvartzman ACS Biomaterials Science & Engineering 7 (1), 122-132, 2020 | 22 | 2020 |
Nanowire based mechanostimulating platform for tunable activation of natural killer cells V Bhingardive, A Edri, A Kossover, GL Saux, B Khand, O Radinsky, ... Advanced Functional Materials 31 (26), 2103063, 2021 | 17 | 2021 |
NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint A Shemesh, A Kugel, N Steiner, M Yezersky, D Tirosh, A Edri, O Teltsh, ... Oncotarget 7 (43), 70912, 2016 | 17 | 2016 |
Molecular-scale spatio-chemical control of the activating-inhibitory signal integration in NK cells E Toledo, G Le Saux, A Edri, L Li, M Rosenberg, Y Keidar, V Bhingardive, ... Science advances 7 (24), eabc1640, 2021 | 15 | 2021 |
N-Glycans mediate the ebola virus-GP1 shielding of ligands to immune receptors and immune evasion M Iraqi, A Edri, Y Greenshpan, K Kundu, P Bolel, A Cahana, A Ottolenghi, ... Frontiers in cellular and infection microbiology 10, 48, 2020 | 15 | 2020 |
Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRI O Radinsky, A Edri, M Brusilovsky, S Fedida-Metula, A Sobarzo, ... Scientific Reports 7 (1), 6054, 2017 | 15 | 2017 |
Fc-independent protection from SARS-CoV-2 infection by recombinant human monoclonal antibodies T Noy-Porat, A Edri, R Alcalay, E Makdasi, D Gur, M Aftalion, Y Evgy, ... Antibodies 10 (4), 45, 2021 | 11 | 2021 |
Nanowire based guidance of the morphology and cytotoxic activity of natural killer cells V Bhingardive, G Le Saux, A Edri, A Porgador, M Schvartzman Small 17 (14), 2007347, 2021 | 11 | 2021 |
Spatial and chemical surface guidance of NK cell cytotoxic activity G Le Saux, A Edri, Y Keydar, U Hadad, A Porgador, M Schvartzman ACS applied materials & interfaces 10 (14), 11486-11494, 2018 | 10 | 2018 |
Nanocomposite coatings for the prevention of surface contamination by coronavirus E Toledo, S Dim, A Edri, Y Greenshpan, A Ottolenghi, N Eisner, S Tzadka, ... Plos one 17 (8), e0272307, 2022 | 5 | 2022 |
Blocking the PCNA/NKp44 checkpoint to stimulate NK cell responses to multiple myeloma M Iraqi, A Edri, Y Greenshpan, O Goldstein, N Ofir, P Bolel, M Abu Ahmad, ... International Journal of Molecular Sciences 23 (9), 4717, 2022 | 5 | 2022 |
Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors A Sobarzo, SW Stonier, O Radinsky, S Gelkop, AI Kuehne, A Edri, ... EBioMedicine 46, 215-226, 2019 | 4 | 2019 |
Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies. Antibodies 2021, 10, 45 T Noy-Porat, A Edri, R Alcalay, E Makdasi, D Gur, M Aftalion, Y Evgy, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 2 | 2021 |
mAb14, a monoclonal antibody against cell surface PCNA: A potential tool for sezary syndrome diagnosis and targeted immunotherapy J Knaneh, E Hodak, S Fedida-Metula, A Edri, R Eren, Y Yoffe, ... Cancers 15 (17), 4421, 2023 | 1 | 2023 |